Table 2.
Multivariate analysis to explore risk factors for presence of DRTB, MDRTB, RRTB and INH mono-resistance
| DRTB OR (95% CI) |
MDRTB OR (95% CI) |
RRTB OR (95% CI) |
INH mono-resistance OR (95% CI) |
|
|---|---|---|---|---|
| Age < 30 | ||||
| Age 31–60 | 1.0 (0.2–4.3) | 0.4 (0.1–4.5) | 0.3 (0.1–2.9) | 1.4 (0.3–6.0) |
| Age > 60 | 1.2 (0.3–4.4) | 0.4 (0.1–3.9) | 0.4 (0.1–3.3) | 1.4 (0.4–5.1) |
| Gender | 1.0 (0.5–2.1) | 1.4 (0.5–3.6) | 1.5 (0.6–3.7) | 0.9 (0.4–1.9) |
| HIV-Duration < 5 | ||||
| 6–10 years | 0.8 (0.3–2.3) | 0.6 (0.2–2.4) | 0.7 (0.3–2.3) | 0.8 (0.2–2.4) |
| > 10 years | 1.6 (0.5–4.7) | 1.1(0.3–5.1) | 1.3 (0.5–4.7) | 1.5 (0.3–4.9) |
| CD4 counts < 50 | ||||
| 51–100 | 0.6 (0.2–1.8) | 0.2 (0.1–1.2) | 0.3 (0.1–1.2) | 0.6 (0.2–1.8) |
| > 100 | 0.7 (0.3–1.6) | 0.5 (0.1–1.2) | 0.5 (0.1–1.5) | 0.7 (0.3–1.7) |
| ART status | 1.0 (0.5–2.4) | 1.1 (0.4–3.2) | 1.2 (0.5–3.1) | 1.0 (0.4–2.4) |
| Type of TB: EPTB | 0.6 (0.3–1.3) | 0.5 (0.1–1.2) | 0.6 (0.2–1.4) | 0.6 (0.3–1.2) |
| Primary and relapse | 2.4 (1.2–4.9)* | 2.5 (1.0–6.3)** | 2.18 (1.0–5.1) | 2.6 (1.2–5.5)*** |
*p = 0.018, **p = 0.048, *** p = 0.012
The outcome variable was treated as dichotomous variable (MDRTB vs non-MDRTB, DRTB vs non-DRTB, RRTB vs non-RRTB and INH mono-resistant TB vs non-INH mono-resistant TB)
Odds Ratio (OR)